Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Apurva A Modi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
AIDS Reviews|May 4, 2007
Viral hepatitis and HIV in AfricaApurva A Modi, Jordan J Feld
Hepatology (Baltimore, Md.)|September 20, 2007
New therapies for hepatitis CApurva A Modi, Jay H Hoofnagle
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2015
Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on haemodialysis or GFR <30 ml/minHector E Nazario, Milka Ndungu, Apurva A Modi
Antiviral Therapy|June 27, 2007
Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a reviewApurva A Modi, Elizabeth C Wright, Leonard B Seeff
Canadian Journal of Gastroenterology & Hepatology|August 18, 2020
Effect of Low Positive End of Treatment Viral Load with Direct-Acting Antiviral Therapy on Sustained Virologic ResponseVabhave Pal, Nirupama Ancha, Jena Mann, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
Increased caffeine consumption is associated with reduced hepatic fibrosisApurva A Modi, Jordan J Feld, Yoon Park, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 4, 2015
Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosisApurva A Modi, Hector Nazario, James F Trotter, et al.
Gastroenterology|September 22, 2010
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonrespondersJordan J Feld, Apurva A Modi, Ramy El-Diwany, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
AIDS Reviews|May 4, 2007
Viral hepatitis and HIV in AfricaApurva A Modi, Jordan J Feld
Hepatology (Baltimore, Md.)|September 20, 2007
New therapies for hepatitis CApurva A Modi, Jay H Hoofnagle
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2015
Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on haemodialysis or GFR <30 ml/minHector E Nazario, Milka Ndungu, Apurva A Modi
Antiviral Therapy|June 27, 2007
Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a reviewApurva A Modi, Elizabeth C Wright, Leonard B Seeff
Canadian Journal of Gastroenterology & Hepatology|August 18, 2020
Effect of Low Positive End of Treatment Viral Load with Direct-Acting Antiviral Therapy on Sustained Virologic ResponseVabhave Pal, Nirupama Ancha, Jena Mann, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
Increased caffeine consumption is associated with reduced hepatic fibrosisApurva A Modi, Jordan J Feld, Yoon Park, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 4, 2015
Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosisApurva A Modi, Hector Nazario, James F Trotter, et al.
Gastroenterology|September 22, 2010
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonrespondersJordan J Feld, Apurva A Modi, Ramy El-Diwany, et al.
Pageof 1